# SonarMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sonarmed

- Industry: Medical Devices & Equipment
- Headquarters: Carmel, US
- Website: www.sonarmed.com
- Total disclosed funding: $4.3M
- Latest round: Series C (May 1, 2017)
- Investors on record: 9

## About

SonarMed, Inc. is a healthcare technology company focused on developing innovative solutions in respiratory monitoring. Their mission is to enhance patient safety and outcomes through sophisticated monitoring systems.SonarMed, Inc. provides advanced respiratory monitoring solutions designed to improve patient outcomes in critical care environments. Founded in 2005 and headquartered in Carmel, US, the company has seen strategic developments, including securing USD 3.000 mn in Series C funding on May 1, 2017, led by South Coast Angel Network, with contributions from several other investors. Jeff Mansfield is the founder of the company, while Tom Bumgardner serves as the CEO.SonarMed, Inc. specializes in respiratory monitoring products aimed at addressing significant healthcare challenges. Their offerings include advanced monitoring systems specifically designed to improve care for patients with chronic respiratory conditions. These products are utilized by hospitals and healthcare providers globally, facilitating enhanced patient management in both acute and home care settings.SonarMed, Inc. generates revenue through direct sales of its respiratory monitoring systems to healthcare facilities. The company engages in business-to-business transactions, focusing on providing innovative solutions for critical care needs. Revenue streams are bolstered by partnerships with healthcare institutions that utilize these monitoring technologies to support patient care.SonarMed, Inc. plans to leverage the recent Series C funding of USD 3.000 mn to expand its product offerings and improve its market presence. The company aims to enhance its respiratory monitoring technology and develop new products suited for acute and home care environments. Additionally, SonarMed is exploring opportunities for geographic expansion into North America and Europe to broaden its customer base and address the growing demand for respiratory support solutions.

## Funding rounds

- Series C, May 1, 2017, $3M — Spring Mill Venture Partners, BioCrossroads, Queen City Angels, Baylor Angel Network, Hyde Park Angels, Central Texas Angel Network, South Coast Angel Network, VisionTech Partners
- Series A, Sep 10, 2010, $1M — Spring Mill Venture Partners, BioCrossroads, Queen City Angels, Hyde Park Angels, StepStone Angels
- Seed, Feb 28, 2006, $0.3M — BioCrossroads

## Investors

- BioCrossroads (https://capitalatlas.ai/funds/biocrossroads) — Seed, Series A, Series C
- Spring Mill Venture Partners (https://capitalatlas.ai/funds/spring-mill-venture-partners) — Series A, Series C
- Queen City Angels (https://capitalatlas.ai/funds/queen-city-angels) — Series A, Series C
- Hyde Park Angels (https://capitalatlas.ai/funds/hyde-park-angels) — Series A, Series C
- StepStone Angels — Series A
- Baylor Angel Network (https://capitalatlas.ai/funds/baylor-angel-network) — Series C
- Central Texas Angel Network — Series C
- South Coast Angel Network — Series C
- VisionTech Partners (https://capitalatlas.ai/funds/visiontech-partners) — Series C